← Leaderboards
Christopher P Cardozo
James J Peters Va Medical Center
$1,203,045
Attributed
$2,406,090
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $529.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,406,090 · 1
VA$0 · 11
By mechanism
R01$2,406,090 · 1
I01$0 · 6
I21$0 · 1
IS1$0 · 4
Top collaborators
- Marco Brotto7 shared
- Helen M. Bramlett5 shared
- Daniel Kacy Cullen2 shared
- Dan Ding2 shared
- Ann Michele Spungen2 shared
Most similar at James J Peters Va Medical Center
Same institution · by research overlap
- Ann Michele Spungen$0
- Noam Y. Harel$3,014,484
- John C He$22,416,030
- Wei Zhao$0
- Christopher Cirnigliaro$0
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeVeteransPreventMuscleSpinal Cord InjuryPharmaceutical PreparationsInjuryImpairmentMolecularMuscular AtrophyAffectLeadGenesFutureKnock-OutLinkCellsFiberFunctional DisorderSignal TransductionAgingAtrophicOverexpressionMuscle Function
Grant awards (33)
Non-selective membrane channel blockers for mTBI$0
I21 · FY2025 · VA · contact PI
Design Improvements and Evaluation of a Knee Stress-Relief Powered Exoskeleton for Veterans with Knee Osteoarthritis$0
I01 · FY2025 · VA · contact PI
Connexin Hemichannel Blockers to Preserve Muscle Function and Improve Recovery After Neuromuscular Trauma$0
I01 · FY2025 · VA
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI$0
I01 · FY2025 · VA · contact PI
Connexin Hemichannel Blockers to Preserve Muscle Function and Improve Recovery After Neuromuscular Trauma$0
I01 · FY2025 · VA
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI$0
I01 · FY2024 · VA · contact PI
Non-selective membrane channel blockers for mTBI$0
I21 · FY2024 · VA · contact PI
Design Improvements and Evaluation of a Knee Stress-Relief Powered Exoskeleton for Veterans with Knee Osteoarthritis$0
I01 · FY2024 · VA · contact PI
ShEEP Request for a Multimodal Plate Reader$0
IS1 · FY2023 · VA · contact PI
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI$0
I01 · FY2023 · VA · contact PI
Loss of Numb in Muscle Dysfunction in Aging$446,969
R01 · FY2022 · AG · contact PI
Loss of Numb in Muscle Dysfunction in Aging$54,825
R01 · FY2022 · AG · contact PI
Loss of Numb in Muscle Dysfunction in Aging$27,412
R01 · FY2022 · AG · contact PI
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI$0
I01 · FY2022 · VA · contact PI
Role of ryanodine receptor dysfunction after spinal cord injury$0
I01 · FY2022 · VA · contact PI
Loss of Numb in Muscle Dysfunction in Aging$458,565
R01 · FY2021 · AG · contact PI
ShEEP-IC: Jess Simple Western System$0
IS1 · FY2021 · VA · contact PI
Loss of Numb in Muscle Dysfunction in Aging$466,559
R01 · FY2020 · AG · contact PI
Role of ryanodine receptor dysfunction after spinal cord injury$0
I01 · FY2020 · VA · contact PI
Loss of Numb in Muscle Dysfunction in Aging$472,304
R01 · FY2019 · AG · contact PI
ShEEP Request for A Metabolic and Behavioral Phenotyping System$0
IS1 · FY2019 · VA · contact PI
Role of ryanodine receptor dysfunction after spinal cord injury$0
I01 · FY2019 · VA · contact PI
Loss of Numb in Muscle Dysfunction in Aging$479,456
R01 · FY2018 · AG · contact PI
Role of ryanodine receptor dysfunction after spinal cord injury$0
I01 · FY2018 · VA · contact PI
Role of ryanodine receptor dysfunction after spinal cord injury$0
I01 · FY2017 · VA · contact PI
[ShEEP/LAMb] Request for a Seahorse Extracellular Flux Analyzer$0
IS1 · FY2016 · VA · contact PI
Notch and Wnt signaling in protection by nandrolone against disuse atrophy$0
I01 · FY2015 · VA · contact PI
Notch and Wnt signaling in protection by nandrolone against disuse atrophy$0
I01 · FY2014 · VA · contact PI
Notch and Wnt signaling in protection by nandrolone against disuse atrophy$0
I01 · FY2014 · VA · contact PI
Attenuation of denervation atrophy by nandrolone: molecular mechanisms$0
I01 · FY2014 · VA · contact PI
Attenuation of denervation atrophy by nandrolone: molecular mechanisms$0
I01 · FY2014 · VA · contact PI
Notch and Wnt signaling in protection by nandrolone against disuse atrophy$0
I01 · FY2012 · VA · contact PI
Attenuation of denervation atrophy by nandrolone: molecular mechanisms$0
I01 · FY2009 · VA · contact PI